Tag:

LFB Technologies

Latest Headlines

Thallion inks $130M licensing deal with LFB

February 16, 2010

Canada's Thallion Pharmaceuticals has inked a $130 million licensing deal with LFB Technologies covering the further development and commercialization of a new treatment for Shiga toxin-producing E.

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Quality Assurance Specialist Job
Yoh - Lexington, MA, USA
Director, Safety Pharmacology and Toxicology
Tesaro - Waltham, MA
Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA
Analytical Scientist Job
Yoh - Durham, NC, USA
Supervisor, QC Chemistry - 3rd Shift Job
Celgene Corporation - Phoenix, AZ, US

LFB Technologies

Latest Headlines

Latest Headlines

Thallion inks $130M licensing deal with LFB

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

LFB Technologies

Latest Headlines

Latest Headlines

Thallion inks $130M licensing deal with LFB

Related Tags